Literature DB >> 17428896

Temporal-spatial expression of ANG-(1-7) and angiotensin-converting enzyme 2 in the kidney of normal and hypertensive pregnant rats.

J Joyner1, L A A Neves, J P Granger, B T Alexander, D C Merrill, M C Chappell, C M Ferrario, W P Davis, K B Brosnihan.   

Abstract

We recently demonstrated that renin-angiotensin system (RAS) overactivity during late gestation in rats is associated with increased kidney and urine levels of ANG-(1-7) and enhanced kidney immunostaining of ANG-(1-7) and angiotensin-converting enzyme 2 (ACE2). To understand the temporal-spatial changes in normal and hypertensive pregnancies, the renal distribution of ANG-(1-7) and ACE2 in association with kidney angiotensin peptides and ACE2 activity was examined in virgin, normal pregnant (NP; gestational days 5, 15, and 19) and reduced uterine perfusion pressure (RUPP at day 19) pregnant Sprague-Dawley rats. ANG-(1-7) and ACE2 immunocytochemical staining increased 1.8- and 1.9-fold and 1.7- and 1.8-fold, respectively, at days 15 and 19 of NP, compared with virgin rats. ANG-(1-7) and ANG II concentrations were increased in the kidney at 19 days of gestation. ACE2 activity measured using a fluorescent substrate was increased 1.9- and 1.9-fold in the cortex and 1.9- and 1.8-fold in the medulla at days 15 and 19 of NP. In the RUPP animals, ANG-(1-7) immunostaining and concentration were significantly decreased compared with 19-day NP rats. ACE2 activity was unchanged in the cortex and medulla of RUPP rats. In conclusion, during NP, the concurrent changes of ACE2 and ANG-(1-7) suggest that ACE2 plays an important role in regulating the renal levels of ANG-(1-7) at mid to late gestation. However, the decrease in renal ANG-(1-7) content in the absence of a concomitant decrease in ACE2 implicates the participation of other ANG-(1-7) forming or degrading enzymes during hypertensive pregnancy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17428896     DOI: 10.1152/ajpregu.00387.2006

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  32 in total

1.  Advances in the renin angiotensin system focus on angiotensin-converting enzyme 2 and angiotensin-(1-7).

Authors:  Carlos M Ferrario; Sarfaraz Ahmad; Janae Joyner; Jasmina Varagic
Journal:  Adv Pharmacol       Date:  2010

Review 2.  Molecular mechanisms and regulation of urinary acidification.

Authors:  Ira Kurtz
Journal:  Compr Physiol       Date:  2014-10       Impact factor: 9.090

3.  Protective regulation of the ACE2/ACE gene expression by estrogen in human atrial tissue from elderly men.

Authors:  A Bukowska; L Spiller; C Wolke; U Lendeckel; S Weinert; J Hoffmann; P Bornfleth; I Kutschka; A Gardemann; B Isermann; A Goette
Journal:  Exp Biol Med (Maywood)       Date:  2017-06-29

4.  A novel rodent model of pregnancy complications associated with genetically determined angiotensin-converting enzyme (ACE) activity.

Authors:  Eugenia Mata-Greenwood; Arlin B Blood; LeeAnna D Sands; Shannon L Bragg; Daliao Xiao; Lubo Zhang
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-01-23       Impact factor: 4.310

Review 5.  Renin-angiotensin system in the kidney: What is new?

Authors:  Fernanda M Ferrão; Lucienne S Lara; Jennifer Lowe
Journal:  World J Nephrol       Date:  2014-08-06

6.  Regulation of angiotensin-(1-7) and angiotensin II type 1 receptor by telmisartan and losartan in adriamycin-induced rat heart failure.

Authors:  Wen-na Zong; Xiao-hui Yang; Xiu-mei Chen; Hong-juan Huang; Hong-jian Zheng; Xiao-yi Qin; Yong-hong Yong; Kejiang Cao; Jun Huang; Xin-zheng Lu
Journal:  Acta Pharmacol Sin       Date:  2011-10-03       Impact factor: 6.150

7.  Angiotensin-converting enzyme 2 deficiency is associated with impaired gestational weight gain and fetal growth restriction.

Authors:  Manish S Bharadwaj; William B Strawn; Leanne Groban; Liliya M Yamaleyeva; Mark C Chappell; Carina Horta; Katie Atkins; Luciana Firmes; Susan B Gurley; K Bridget Brosnihan
Journal:  Hypertension       Date:  2011-10-03       Impact factor: 10.190

8.  Does ACE2 contribute to the development of hypertension?

Authors:  Mark C Chappell
Journal:  Hypertens Res       Date:  2009-12-18       Impact factor: 3.872

Review 9.  Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19, and the Renin-Angiotensin System: Pressing Needs and Best Research Practices.

Authors:  Matthew A Sparks; Andrew M South; Andrew D Badley; Carissa M Baker-Smith; Daniel Batlle; Biykem Bozkurt; Roberto Cattaneo; Steven D Crowley; Louis J Dell'Italia; Andria L Ford; Kathy Griendling; Susan B Gurley; Scott E Kasner; Joseph A Murray; Karl A Nath; Marc A Pfeffer; Janani Rangaswami; W Robert Taylor; Vesna D Garovic
Journal:  Hypertension       Date:  2020-09-28       Impact factor: 10.190

Review 10.  New angiotensins.

Authors:  Jasmina Varagic; Aaron J Trask; Jewell A Jessup; Mark C Chappell; Carlos M Ferrario
Journal:  J Mol Med (Berl)       Date:  2008-04-25       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.